Cargando…

166. Impact of Pneumonia Panel Implementation with Stewardship Support on Antibiotic De-escalation in the ICU

BACKGROUND: Pneumonia is the most common indication for antibiotics in the ICU. Better diagnostic tools are needed to target therapy. We evaluated the impact of the BIOFIRE Pneumonia Panel (PNP) coupled with aggressive stewardship interventions in the ICU. METHODS: The PNP was implemented 5/2020 wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Schooneveld, Trevor C Van, Bergman, Scott J, Lyden, Elizabeth, Fey, Paul, Miller, Molly M, Kate Anderson, Mary, Kashyap, Akshay, Mantz, Sara, Vetter, Rachel, Wurtz, Paul, Stohs, Erica J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678904/
http://dx.doi.org/10.1093/ofid/ofad500.239
_version_ 1785150467634888704
author Schooneveld, Trevor C Van
Bergman, Scott J
Lyden, Elizabeth
Fey, Paul
Miller, Molly M
Kate Anderson, Mary
Kashyap, Akshay
Mantz, Sara
Vetter, Rachel
Wurtz, Paul
Stohs, Erica J
author_facet Schooneveld, Trevor C Van
Bergman, Scott J
Lyden, Elizabeth
Fey, Paul
Miller, Molly M
Kate Anderson, Mary
Kashyap, Akshay
Mantz, Sara
Vetter, Rachel
Wurtz, Paul
Stohs, Erica J
author_sort Schooneveld, Trevor C Van
collection PubMed
description BACKGROUND: Pneumonia is the most common indication for antibiotics in the ICU. Better diagnostic tools are needed to target therapy. We evaluated the impact of the BIOFIRE Pneumonia Panel (PNP) coupled with aggressive stewardship interventions in the ICU. METHODS: The PNP was implemented 5/2020 with interpretation guidance, provider education, and intermittent stewardship feedback. From 2/21 to 7/21 (Intervention) stewardship personnel reviewed all ICU PNP and provided structured feedback. We compared this group to patients with a respiratory tract culture in the ICU 9/19-2/20 (Control). We evaluated only first PNP/culture and excluded age < 19 years and expired < 24 hours after PNP/culture. Antibiotic use for 7 days after PNP/culture was compared between groups with time to de-escalation as the primary outcome. Times were measured from PNP/culture collection. RESULTS: A total of 313 intervention patients and 315 controls were compared with differences noted in ICU location and LOS, COVID detection, specimen type, and mortality (Table 1). PNP results were available 4 hours after collection and positive in 56.9% (culture positive 38.3%) with the most common pathogens detected being S. aureus (MSSA 61, MRSA 28), H. influnezae (32), respiratory viruses (30), and P. aeruginosa (24). Use of urine antigens and respiratory pathogen panel testing was less common in the Intervention group (Table 1) while stewardship interventions were more common (82% vs. 13%) and occurred 23 hours earlier (Table 2). Intervention period antibiotic de-escalation occurred 18 hours earlier (P< 0.0001) and time to stopping anti-MRSA and anti-Pseudomonal therapy was shorter (absolute difference 13 hours, P=0.005 and 16 hours, P=0.060). Median antibiotic days were decreased (9 vs. 8, P=0.008) and days of vancomycin, metronidazole, azithromycin, and Anti-Pseudomonal therapy significantly decreased during the intervention. [Figure: see text] [Figure: see text] CONCLUSION: PNP detected more pathogens and when coupled with an aggressive stewardship intervention resulted in faster pathogen detection, decreased urine antigen testing, faster de-escalation of antibiotics, and less antibiotic use. Clinical characteristics and outcomes were different between the groups which may be due to differences in the populations including the presence of COVID. DISCLOSURES: Trevor C. Van Schooneveld, MD, FSHEA, FACP, AN2 Therapeutics: Grant/Research Support|Biomeriuex: Advisor/Consultant|Biomeriuex: Grant/Research Support|Insmed: Grant/Research Support|Thermo-Fischer: Honoraria Scott J. Bergman, PharmD, bioMerieux, Inc.: Honoraria Erica J. Stohs, MD, MPH, bioMerieux: Grant/Research Support|Merck: Grant/Research Support
format Online
Article
Text
id pubmed-10678904
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106789042023-11-27 166. Impact of Pneumonia Panel Implementation with Stewardship Support on Antibiotic De-escalation in the ICU Schooneveld, Trevor C Van Bergman, Scott J Lyden, Elizabeth Fey, Paul Miller, Molly M Kate Anderson, Mary Kashyap, Akshay Mantz, Sara Vetter, Rachel Wurtz, Paul Stohs, Erica J Open Forum Infect Dis Abstract BACKGROUND: Pneumonia is the most common indication for antibiotics in the ICU. Better diagnostic tools are needed to target therapy. We evaluated the impact of the BIOFIRE Pneumonia Panel (PNP) coupled with aggressive stewardship interventions in the ICU. METHODS: The PNP was implemented 5/2020 with interpretation guidance, provider education, and intermittent stewardship feedback. From 2/21 to 7/21 (Intervention) stewardship personnel reviewed all ICU PNP and provided structured feedback. We compared this group to patients with a respiratory tract culture in the ICU 9/19-2/20 (Control). We evaluated only first PNP/culture and excluded age < 19 years and expired < 24 hours after PNP/culture. Antibiotic use for 7 days after PNP/culture was compared between groups with time to de-escalation as the primary outcome. Times were measured from PNP/culture collection. RESULTS: A total of 313 intervention patients and 315 controls were compared with differences noted in ICU location and LOS, COVID detection, specimen type, and mortality (Table 1). PNP results were available 4 hours after collection and positive in 56.9% (culture positive 38.3%) with the most common pathogens detected being S. aureus (MSSA 61, MRSA 28), H. influnezae (32), respiratory viruses (30), and P. aeruginosa (24). Use of urine antigens and respiratory pathogen panel testing was less common in the Intervention group (Table 1) while stewardship interventions were more common (82% vs. 13%) and occurred 23 hours earlier (Table 2). Intervention period antibiotic de-escalation occurred 18 hours earlier (P< 0.0001) and time to stopping anti-MRSA and anti-Pseudomonal therapy was shorter (absolute difference 13 hours, P=0.005 and 16 hours, P=0.060). Median antibiotic days were decreased (9 vs. 8, P=0.008) and days of vancomycin, metronidazole, azithromycin, and Anti-Pseudomonal therapy significantly decreased during the intervention. [Figure: see text] [Figure: see text] CONCLUSION: PNP detected more pathogens and when coupled with an aggressive stewardship intervention resulted in faster pathogen detection, decreased urine antigen testing, faster de-escalation of antibiotics, and less antibiotic use. Clinical characteristics and outcomes were different between the groups which may be due to differences in the populations including the presence of COVID. DISCLOSURES: Trevor C. Van Schooneveld, MD, FSHEA, FACP, AN2 Therapeutics: Grant/Research Support|Biomeriuex: Advisor/Consultant|Biomeriuex: Grant/Research Support|Insmed: Grant/Research Support|Thermo-Fischer: Honoraria Scott J. Bergman, PharmD, bioMerieux, Inc.: Honoraria Erica J. Stohs, MD, MPH, bioMerieux: Grant/Research Support|Merck: Grant/Research Support Oxford University Press 2023-11-27 /pmc/articles/PMC10678904/ http://dx.doi.org/10.1093/ofid/ofad500.239 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Schooneveld, Trevor C Van
Bergman, Scott J
Lyden, Elizabeth
Fey, Paul
Miller, Molly M
Kate Anderson, Mary
Kashyap, Akshay
Mantz, Sara
Vetter, Rachel
Wurtz, Paul
Stohs, Erica J
166. Impact of Pneumonia Panel Implementation with Stewardship Support on Antibiotic De-escalation in the ICU
title 166. Impact of Pneumonia Panel Implementation with Stewardship Support on Antibiotic De-escalation in the ICU
title_full 166. Impact of Pneumonia Panel Implementation with Stewardship Support on Antibiotic De-escalation in the ICU
title_fullStr 166. Impact of Pneumonia Panel Implementation with Stewardship Support on Antibiotic De-escalation in the ICU
title_full_unstemmed 166. Impact of Pneumonia Panel Implementation with Stewardship Support on Antibiotic De-escalation in the ICU
title_short 166. Impact of Pneumonia Panel Implementation with Stewardship Support on Antibiotic De-escalation in the ICU
title_sort 166. impact of pneumonia panel implementation with stewardship support on antibiotic de-escalation in the icu
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678904/
http://dx.doi.org/10.1093/ofid/ofad500.239
work_keys_str_mv AT schooneveldtrevorcvan 166impactofpneumoniapanelimplementationwithstewardshipsupportonantibioticdeescalationintheicu
AT bergmanscottj 166impactofpneumoniapanelimplementationwithstewardshipsupportonantibioticdeescalationintheicu
AT lydenelizabeth 166impactofpneumoniapanelimplementationwithstewardshipsupportonantibioticdeescalationintheicu
AT feypaul 166impactofpneumoniapanelimplementationwithstewardshipsupportonantibioticdeescalationintheicu
AT millermollym 166impactofpneumoniapanelimplementationwithstewardshipsupportonantibioticdeescalationintheicu
AT kateandersonmary 166impactofpneumoniapanelimplementationwithstewardshipsupportonantibioticdeescalationintheicu
AT kashyapakshay 166impactofpneumoniapanelimplementationwithstewardshipsupportonantibioticdeescalationintheicu
AT mantzsara 166impactofpneumoniapanelimplementationwithstewardshipsupportonantibioticdeescalationintheicu
AT vetterrachel 166impactofpneumoniapanelimplementationwithstewardshipsupportonantibioticdeescalationintheicu
AT wurtzpaul 166impactofpneumoniapanelimplementationwithstewardshipsupportonantibioticdeescalationintheicu
AT stohsericaj 166impactofpneumoniapanelimplementationwithstewardshipsupportonantibioticdeescalationintheicu